60 related articles for article (PubMed ID: 9280773)
1. [Case of dilated cardiomyopathy with marked improvement of the cardiac function with beta block treatment and exacerbation with the interruption of the treatment].
Shimizu K; Morimoto S; Yamada K; Hiramitsu S; Uemura A; Kubo N; Kimura K; Kato Y; Kato S; Hishida H
Nihon Naika Gakkai Zasshi; 1997 May; 86(5):840-2. PubMed ID: 9280773
[No Abstract] [Full Text] [Related]
2. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
[TBL] [Abstract][Full Text] [Related]
3. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of heart rate in dilated cardiomyopathy treated with metoprolol.
Perkan A; Di Lenarda A; Sinagra G; Gregori D; Cherubini A; Zecchin M; Gortan R; Klugmann S; Camerini F
G Ital Cardiol; 1997 Nov; 27(11):1106-12. PubMed ID: 9419820
[TBL] [Abstract][Full Text] [Related]
5. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
[TBL] [Abstract][Full Text] [Related]
6. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
[TBL] [Abstract][Full Text] [Related]
7. Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by metoprolol treatment.
Yamada S; Ohkura T; Yamadera T; Ito O; Kimura R; Nozawa Y; Hayashi S; Miyake H
J Pharmacol Exp Ther; 1997 Dec; 283(3):1389-95. PubMed ID: 9400015
[TBL] [Abstract][Full Text] [Related]
8. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy.
Andersson B; Caidahl K; di Lenarda A; Warren SE; Goss F; Waldenström A; Persson S; Wallentin I; Hjalmarson A; Waagstein F
Circulation; 1996 Aug; 94(4):673-82. PubMed ID: 8772687
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
Anderson JL
Postgrad Med; 1988 Feb; Spec No():104-12. PubMed ID: 2894653
[TBL] [Abstract][Full Text] [Related]
10. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
[TBL] [Abstract][Full Text] [Related]
11. [Chronic treatment of dilated cardiomyopathy by beta blocking agents. Clinical and hemodynamic follow-up].
Cucchini F; Compostella L; Papalia D; de Domenico R; Iavernaro A; Zeppellini R
G Ital Cardiol; 1988 Oct; 18(10):835-42. PubMed ID: 2907743
[TBL] [Abstract][Full Text] [Related]
12. [Beta-receptor blockers in dilated cardiomyopathy].
Osterziel KJ
Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
[No Abstract] [Full Text] [Related]
13. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
Lancet; 1998 Apr; 351(9110):1180-1. PubMed ID: 9643698
[No Abstract] [Full Text] [Related]
14. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
[TBL] [Abstract][Full Text] [Related]
15. [Beta-blockade therapy in heart failure. Rational bases of the interpretation of clinical data and clinical evidence in search of rational interpretation].
Branzi A; Rapezzi C
G Ital Cardiol; 1988 Oct; 18(10):843-6. PubMed ID: 2907744
[No Abstract] [Full Text] [Related]
16. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
17. Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
Freudenberger R; Kalman J; Mannino M; Buchholz-Varley C; Ocampo O; Kukin M
Am J Cardiol; 1997 Nov; 80(10):1372-4. PubMed ID: 9388121
[TBL] [Abstract][Full Text] [Related]
18. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
Lohmann FW
Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
[TBL] [Abstract][Full Text] [Related]
19. A sustained increase in beta-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy.
Yamada S; Ohkura T; Uchida S; Inabe K; Iwatani Y; Kimura R; Hoshino T; Kaburagi T
Life Sci; 1996; 58(20):1737-44. PubMed ID: 8637398
[TBL] [Abstract][Full Text] [Related]
20. Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?
Morimoto S; Shimizu K; Yamada K; Hiramitsu S; Hishida H
Am Heart J; 1999 Sep; 138(3 Pt 1):456-9. PubMed ID: 10467195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
